Viewing Study NCT03022006


Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2026-02-25 @ 12:56 AM
Study NCT ID: NCT03022006
Status: UNKNOWN
Last Update Posted: 2017-04-12
First Post: 2017-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C
Sponsor: Norte Study Group
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-01-15
Start Date Type: ACTUAL
Primary Completion Date: 2019-03
Primary Completion Date Type: ESTIMATED
Completion Date: None
Completion Date Type: None
First Submit Date: 2017-01-12
First Submit QC Date: None
Study First Post Date: 2017-01-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-04-11
Last Update Post Date: 2017-04-12
Last Update Post Date Type: ACTUAL